Latest filing published 26 Nov 2007 for VIACELL INC, €8.3M.
No signal scores available.
Biotechnology Value Fund L P discloses dealings in Viacell Inc to SEC (Form 4). Activity is concentrated on a single trading day, 9 November 2007, with 3 filings.
On the market, this insider has only sold: 3 sales, €36.1M in total.
The newest entry dates from 26 November 2007: an open-market sale of €8.3M, in Viacell Inc. Filings reach the SEC (Form 4) feed a median of 17 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations